T-cell covid vaccine patch to commence clinical trials
UK company Emergex is about to undertake clinical trials for a skin patch that may offer longer immunity against Covid-19 than current vaccines. If successful, the vaccine could protect against all coronaviruses. The skin patch vaccine would activate T-cells to target infected cells in the early stages of infection. From there, it is hoped the…